Menu
GeneBe

LAMA5

laminin subunit alpha 5, the group of Laminin subunits|MicroRNA protein coding host genes

Basic information

Region (hg38): 20:62307954-62367312

Links

ENSG00000130702NCBI:3911OMIM:601033HGNC:6485Uniprot:O15230AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • LAMA5-related multisystemic syndrome (Supportive), mode of inheritance: AD
  • nephrotic syndrome, IIa 26 (Moderate), mode of inheritance: AR
  • nephrotic syndrome, IIa 26 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Bent bone dysplasia syndrome 2ARCardiovascularAmong other features, the condition can include atrial septal defects, and awareness may allow early diagnosis and managementCardiovascular; Craniofacial; Musculoskeletal; Renal29534211; 33242826; 35419533
Some individuals with Nephrotic syndrome, type 26 have been reported as being responsive to steroids

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LAMA5 gene.

  • not provided (1040 variants)
  • Inborn genetic diseases (262 variants)
  • LAMA5-related condition (36 variants)
  • Nephrotic syndrome (11 variants)
  • Nephrotic syndrome, IIa 26 (7 variants)
  • not specified (6 variants)
  • Short stature (4 variants)
  • Presynaptic congenital myasthenic syndrome (3 variants)
  • Bent bone dysplasia syndrome 2 (2 variants)
  • Polymicrogyria (2 variants)
  • distinct bent bone dysplasia (2 variants)
  • Severe hydrocephalus;Holoprosencephaly sequence (2 variants)
  • Developmental disorder (1 variants)
  • Congenital omphalocele (1 variants)
  • Malignant tumor of prostate (1 variants)
  • Macroscopic hematuria (1 variants)
  • Familial hematuria (1 variants)
  • High myopia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LAMA5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
12
clinvar
225
clinvar
78
clinvar
315
missense
6
clinvar
506
clinvar
63
clinvar
84
clinvar
659
nonsense
2
clinvar
3
clinvar
5
start loss
0
frameshift
3
clinvar
1
clinvar
4
inframe indel
3
clinvar
1
clinvar
4
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
14
27
18
59
non coding
4
clinvar
78
clinvar
122
clinvar
204
Total 0 11 531 366 285

Highest pathogenic variant AF is 0.0000723

Variants in LAMA5

This is a list of pathogenic ClinVar variants found in the LAMA5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-62308045-C-T not specified Uncertain significance (May 08, 2023)2544898
20-62308109-A-G Benign (Jul 20, 2018)787497
20-62308134-G-A not specified Uncertain significance (Nov 27, 2023)3091140
20-62308135-C-T Benign (Jul 31, 2018)790289
20-62308711-G-A not specified Uncertain significance (Dec 03, 2021)2264034
20-62308736-A-G not specified Uncertain significance (Nov 07, 2022)2223629
20-62308747-A-G not specified Uncertain significance (Jun 29, 2022)2299079
20-62309283-G-A Benign (May 14, 2021)1181666
20-62309336-C-A Uncertain significance (May 31, 2023)1929763
20-62309342-G-A Likely benign (Aug 01, 2023)2711901
20-62309346-G-A LAMA5-related disorder Likely benign (Sep 17, 2023)2061071
20-62309356-T-C Inborn genetic diseases Uncertain significance (May 27, 2022)2291692
20-62309357-G-A LAMA5-related disorder Benign (Jan 25, 2024)787498
20-62309371-C-T not specified • LAMA5-related disorder Benign/Likely benign (Mar 01, 2024)279828
20-62309378-C-T LAMA5-related disorder Likely benign (Jul 27, 2023)3050290
20-62309383-C-G Uncertain significance (May 08, 2020)1678199
20-62309391-G-C LAMA5-related disorder Uncertain significance (May 17, 2023)2634386
20-62309395-T-C Uncertain significance (May 08, 2023)1365364
20-62309398-C-T Inborn genetic diseases Likely benign (Mar 13, 2023)2472629
20-62309399-G-A LAMA5-related disorder Likely benign (May 13, 2021)3060229
20-62309410-G-A Inborn genetic diseases Conflicting classifications of pathogenicity (Oct 13, 2023)2164307
20-62309415-A-G Inborn genetic diseases Uncertain significance (Dec 19, 2022)2337333
20-62309417-C-T LAMA5-related disorder Benign (Jan 25, 2024)777608
20-62309427-C-T Benign (Jan 08, 2024)769100
20-62309438-G-A LAMA5-related disorder Likely benign (May 27, 2023)2143075

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LAMA5protein_codingprotein_codingENST00000252999 8059358
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.006470.99412535301491255020.000594
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.27223012.26e+31.020.00016523392
Missense in Polyphen499570.180.875165807
Synonymous-6.4512409831.260.00007507679
Loss of Function9.48441820.2420.000009881948

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001120.00109
Ashkenazi Jewish0.0006400.000597
East Asian0.0007830.000762
Finnish0.0003430.000323
European (Non-Finnish)0.0007290.000662
Middle Eastern0.0007830.000762
South Asian0.0006630.000621
Other0.0006970.000653

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Small cell lung cancer - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Alpha 6 Beta 4 signaling pathway;Primary Focal Segmental Glomerulosclerosis FSGS;Human Complement System;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Interleukin-4 and 13 signaling;PI3K-Akt Signaling Pathway;Inflammatory Response Pathway;Signal Transduction;prion pathway;Alpha6Beta4Integrin;Laminin interactions;Extracellular matrix organization;agrin in postsynaptic differentiation;Degradation of the extracellular matrix;a6b1 and a6b4 Integrin signaling;Non-integrin membrane-ECM interactions;ECM proteoglycans;MET activates PTK2 signaling;MET promotes cell motility;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Beta1 integrin cell surface interactions;Syndecan-1-mediated signaling events;Alpha6 beta4 integrin-ligand interactions (Consensus)

Intolerance Scores

loftool
0.482
rvis_EVS
3.13
rvis_percentile_EVS
99.28

Haploinsufficiency Scores

pHI
0.710
hipred
Y
hipred_score
0.683
ghis
0.483

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.959

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Lama5
Phenotype
vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
lama5
Affected structure
epidermal cell
Phenotype tag
abnormal
Phenotype quality
shape

Gene ontology

Biological process
angiogenesis;branching involved in ureteric bud morphogenesis;morphogenesis of a polarized epithelium;neural crest cell migration;hair follicle development;cytoskeleton organization;integrin-mediated signaling pathway;muscle organ development;cell recognition;cell population proliferation;morphogenesis of embryonic epithelium;cell migration;cytokine-mediated signaling pathway;cell differentiation;regulation of cell adhesion;extracellular matrix organization;lung development;regulation of cell migration;substrate adhesion-dependent cell spreading;regulation of cell population proliferation;odontogenesis of dentin-containing tooth;endothelial cell differentiation;regulation of embryonic development;focal adhesion assembly;cilium assembly;branching involved in salivary gland morphogenesis;protein localization to plasma membrane
Cellular component
extracellular region;basement membrane;laminin-5 complex;extracellular space;nucleus;neuromuscular junction;synaptic cleft;laminin-10 complex;laminin-11 complex;collagen-containing extracellular matrix;extracellular exosome
Molecular function
integrin binding;extracellular matrix structural constituent